Novel non-nucleotidic STING agonists for cancer immunotherapy

被引：12
作者：
Berger, Gilles [1 ]
Lawler, Sean E. [2 ]
机构：
[1] Univ Libre Bruxelles, Fac Pharm Microbiol Bioorgan & Macromol Chem, Bd Triomphe, B-1050 Brussels, Belgium
[2] Harvard Med Sch, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
FUTURE MEDICINAL CHEMISTRY | 2018年 / 10卷 / 24期
关键词：
cancer immunotherapy; cyclic dinucleotides; STING; CYCLIC GMP-AMP; C-DI-GMP; ACTIVATION; VACCINES; POTENT; CELLS;
D O I：
10.4155/fmc-2018-0367
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2767 / 2770
页数：4
相关论文
共 19 条
[1]   Molecular Pathways: Targeting the Stimulator of InterferonGenes(STING) in the Immunotherapyof Cancer [J].
Corrales, Leticia ;
Gajewski, Thomas F. .
CLINICAL CANCER RESEARCH, 2015, 21 (21) :4774-4779
[2]   Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity [J].
Corrales, Leticia ;
Glickman, Laura Hix ;
McWhirter, Sarah M. ;
Kanne, David B. ;
Sivick, Kelsey E. ;
Katibah, George E. ;
Woo, Seng-Ryong ;
Lemmens, Edward ;
Banda, Tamara ;
Leong, Justin J. ;
Metchette, Ken ;
Dubensky, Thomas W., Jr. ;
Gajewski, Thomas F. .
CELL REPORTS, 2015, 11 (07) :1018-1030
[3]   STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia [J].
Curran, Emily ;
Chen, Xiufen ;
Corrales, Leticia ;
Kline, Douglas E. ;
Dubensky, Thomas W., Jr. ;
Duttagupta, Priyanka ;
Kortylewski, Marcin ;
Kline, Justin .
CELL REPORTS, 2016, 15 (11) :2357-2366
[4]   STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity [J].
Demaria, Olivier ;
De Gassart, Aude ;
Coso, Sanja ;
Gestermann, Nicolas ;
Di Domizio, Jeremy ;
Flatz, Lukas ;
Gaide, Olivier ;
Michielin, Olivier ;
Hwu, Patrick ;
Petrova, Tatiana V. ;
Martinon, Fabio ;
Modlin, Robert L. ;
Speiser, Daniel E. ;
Gilliet, Michel .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (50) :15408-15413
[5]   Type I interferon is selectively required by dendritic cells for immune rejection of tumors [J].
Diamond, Mark S. ;
Kinder, Michelle ;
Matsushita, Hirokazu ;
Mashayekhi, Mona ;
Dunn, Gavin P. ;
Archambault, Jessica M. ;
Lee, Hsiaoju ;
Arthur, Cora D. ;
White, J. Michael ;
Kalinke, Ulrich ;
Murphy, Kenneth M. ;
Schreiber, Robert D. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (10) :1989-2003
[6]   STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade [J].
Fu, Juan ;
Kanne, David B. ;
Leong, Meredith ;
Glickman, Laura Hix ;
McWhirter, Sarah M. ;
Lemmens, Edward ;
Mechette, Ken ;
Leong, Justin J. ;
Lauer, Peter ;
Liu, Weiqun ;
Sivick, Kelsey E. ;
Zeng, Qi ;
Soares, Kevin C. ;
Zheng, Lei ;
Portnoy, Daniel A. ;
Woodward, Joshua J. ;
Pardoll, Drew M. ;
Dubensky, Thomas W., Jr. ;
Kim, Young .
SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (283)
[7]   Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells [J].
Fuertes, Mercedes B. ;
Kacha, Aalok K. ;
Kline, Justin ;
Woo, Seng-Ryong ;
Kranz, David M. ;
Murphy, Kenneth M. ;
Gajewski, Thomas F. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (10) :2005-2016
[8]   Structure-Function Analysis of STING Activation by c[G(2′,5′) pA(3′,5′)p] and Targeting by Antiviral DMXAA [J].
Gao, Pu ;
Ascano, Manuel ;
Zillinger, Thomas ;
Wang, Weiyi ;
Dai, Peihong ;
Serganov, Artem A. ;
Gaffney, Barbara L. ;
Shuman, Stewart ;
Jones, Roger A. ;
Deng, Liang ;
Hartmann, Gunther ;
Barchet, Winfried ;
Tuschl, Thomas ;
Patel, Dinshaw J. .
CELL, 2013, 154 (04) :748-762
[9]   cAMP, c-di-GMP, c-di-AMP and now cGMP: bacteria use them all! [J].
Gomelsky, Mark .
MOLECULAR MICROBIOLOGY, 2011, 79 (03) :562-565
[10]   Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis [J].
Hwang, Wei-Ting ;
Adams, Sarah F. ;
Tahirovic, Emin ;
Hagemann, Ian S. ;
Coukos, George .
GYNECOLOGIC ONCOLOGY, 2012, 124 (02) :192-198
12